Skip to main content

Table 1 Patient’s histories and clinical features at presentation

From: Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib

Patient histories

 Medical history

Chronic obstructive pulmonary disease and surgically treated prostate cancer

 Surgical history

Prostatectomy, cholecystectomy, and hernia repair

 Social history

88 pack-years of smoking and consumption of 2 alcoholic beverages per day; no history of illicit drug use

 Family history

No family history of blood disorders, clotting disorders, or malignancies

Clinical features at presentation

 White blood cell count, cells/μL

147,000

 Basophils, %

10

 Absolute neutrophil count, cells/μL

116,210

 Platelet count, platelets/μL

230,000

 Hemoglobin, g/dL

13.1

 Abdominal ultrasound

Splenomegaly of ≈ 16 cm

 Lactate dehydrogenase, U/L

1005